Review



cbd in methanol  (Cayman Chemical)


Bioz Verified Symbol Cayman Chemical is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cayman Chemical cbd in methanol
    Cbd In Methanol, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/Cannabidiol+CRM+solution+in+methanol/bio_rxiv__2025__09__25__678534-194-9-12
    Average 93 stars, based on 1 article reviews
    cbd in methanol - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: Antiviral and Anti-inflammatory Effects of Cannabidiol in HIV/SIV Infection
    Article Snippet: The following compounds were prepared in their respective diluents: CBD in methanol (Cayman Chemical Company ISO60156; Ann Arbor, MI, USA), Bay 11 (Cell Signaling Technology 78679; Danvers, Massachusetts, USA) in ethanol, Baricitinib (AmBeed 1187594-09-7; Buffalo Grove, Illinois, USA) in DMSO, and JWH-133 in DMSO vehicle (Tocris 1343; Minneapolis, Minnesota, USA).



    Similar Products

    93
    Cayman Chemical cbd in methanol
    Cbd In Methanol, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/Cannabidiol+CRM+solution+in+methanol/bio_rxiv__2025__09__25__678534-194-9-12
    Average 93 stars, based on 1 article reviews
    cbd in methanol - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Cayman Chemical cbd
    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol <t>(CBD)</t> supplementation; or ( iii <t>)</t> <t>methanol</t> (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.
    Cbd, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/Cannabidiol+CRM+solution+in+methanol/bio_rxiv__2025__06__13__659599-192-168-169
    Average 93 stars, based on 1 article reviews
    cbd - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Dr Ehrenstorfer GmbH cannabidiol (cbd) solution 1000 ug/ml in methanol
    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol <t>(CBD)</t> supplementation; or ( iii <t>)</t> <t>methanol</t> (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.
    Cannabidiol (Cbd) Solution 1000 Ug/Ml In Methanol, supplied by Dr Ehrenstorfer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cannabidiol++cbd++solution+1000+ug+ml+in+methanol/10__3390_slash_ph18020202-220-0-10
    Average 90 stars, based on 1 article reviews
    cannabidiol (cbd) solution 1000 ug/ml in methanol - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore cbd and thc solution in methanol analytical standards
    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol <t>(CBD)</t> supplementation; or ( iii <t>)</t> <t>methanol</t> (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.
    Cbd And Thc Solution In Methanol Analytical Standards, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cbd+and+thc+solution+in+methanol+analytical+standards/pm37819769-62-10-14
    Average 90 stars, based on 1 article reviews
    cbd and thc solution in methanol analytical standards - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore cannabidiol (cbd; cannabidiol solution methanol
    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol <t>(CBD)</t> supplementation; or ( iii <t>)</t> <t>methanol</t> (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.
    Cannabidiol (Cbd; Cannabidiol Solution Methanol, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cannabidiol++cbd++cannabidiol+solution+methanol/pm37845710-67-16-22
    Average 90 stars, based on 1 article reviews
    cannabidiol (cbd; cannabidiol solution methanol - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    92
    Millipore 7 oh cbd
    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol <t>(CBD)</t> supplementation; or ( iii <t>)</t> <t>methanol</t> (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.
    7 Oh Cbd, supplied by Millipore, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/7-Hydroxy+cannabidiol+(7-OH-CBD)+in+Methanol/bio_rxiv__2023__06__16__545309-207-17-13
    Average 92 stars, based on 1 article reviews
    7 oh cbd - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    90
    Cayman Chemical cbd-d9 (1 in methanol)
    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol <t>(CBD)</t> supplementation; or ( iii <t>)</t> <t>methanol</t> (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.
    Cbd D9 (1 In Methanol), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cbd+powder/pm36372912-97-2-11
    Average 90 stars, based on 1 article reviews
    cbd-d9 (1 in methanol) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore cbd methanol solution at 1 mg/ml
    Contents of the main cannabinoids in Cannabis FM2 in the starting material and after decarboxylation at different temperatures, namely 115 and 125 °C. Results are expressed as mean (%, w/w) ± standard deviation (CV%).
    Cbd Methanol Solution At 1 Mg/Ml, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cbd+methanol+solution+at+1+mg+ml/pmc09785504-108-12-37
    Average 90 stars, based on 1 article reviews
    cbd methanol solution at 1 mg/ml - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore cannabidiol (cbd, 1 mg/ml in methanol)
    Contents of the main cannabinoids in Cannabis FM2 in the starting material and after decarboxylation at different temperatures, namely 115 and 125 °C. Results are expressed as mean (%, w/w) ± standard deviation (CV%).
    Cannabidiol (Cbd, 1 Mg/Ml In Methanol), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cannabidiol+d3++cbd+d3/pmc09261791-76-8-53
    Average 90 stars, based on 1 article reviews
    cannabidiol (cbd, 1 mg/ml in methanol) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore cannabidiol-d 3 (cbd-d 3 , 0.1 mg/ml in methanol)
    Contents of the main cannabinoids in Cannabis FM2 in the starting material and after decarboxylation at different temperatures, namely 115 and 125 °C. Results are expressed as mean (%, w/w) ± standard deviation (CV%).
    Cannabidiol D 3 (Cbd D 3 , 0.1 Mg/Ml In Methanol), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cbd+in+methanol/cannabidiol+d3++cbd+d3/pmc09261791-76-31-53
    Average 90 stars, based on 1 article reviews
    cannabidiol-d 3 (cbd-d 3 , 0.1 mg/ml in methanol) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol (CBD) supplementation; or ( iii ) methanol (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.

    Journal: bioRxiv

    Article Title: Oviduct fluid metabolic regulation of embryonic genome methylation

    doi: 10.1101/2025.06.13.659599

    Figure Lengend Snippet: ( A ) Representative in vivo bovine oviduct histoarchitecture at Day 5, showing cannabinoid receptor 1 (CB1) and 2 (CB2) expression. ( B ) Representative control group organoid CB1 and CB2 expression. ( C ) Independent experimental variables – ( i ) 17β-estradiol (E2) with medroxyprogesterone acetate (MPA); ( ii ) E2 and MPA plus Δ⁹-tetrahydrocannabinol (THC) and cannabidiol (CBD) supplementation; or ( iii ) methanol (control) supplementation for 144 h. ( D ) Representative organoid brightfield images across treatments and time. Note: Yellow borders are software generated. ( E - G ) Mean (±SEM) organoid (n=4) morphometric kinetics – ( E ) count, ( F ) circularity, and ( G ) area. Select differences observed [ P ≤0.05 (*) and P ≤0.0001 (****)]. ( H ) Representative organoid Ki67 expression following pathological mimic (THC+CBD) supplementation. ( I ) Heatmap of differentially expressed genes (DEG) by treatment, grouped into six clusters. ( J ) Multivariate plot of DEG pathway significance and impact according to cluster. Bubble size is proportional to the impact ratio (number of genes divided by total pathway size), whereas the vertical axis unit is inverse false discovery rate (FDR). ( K - M ) DEG between organoid treatments – ( K ) control vs . E2+MPA, ( L ) control vs . THC+CBD, and ( M ) E2+MPA vs . THC+CBD. Yellow, purple, and teal indicate control, E2+MPA, and THC+CBD gene upregulation, respectively. ( N ) Parametric gene set enrichment analysis using gene ontology resource molecular function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations, highlighting activated (red) and suppressed (blue) processes in E2+MPA vs . THC+CBD treated organoids. All scale bars: 100 µm.

    Article Snippet: These were: ( a ) negative control – comprising Base Medium ( Table S2 ); ( b ) E2 – Base Medium supplemented with E2 (Thermo Scientific Chemicals, L0380103) dissolved in methanol (Fisher Chemical, A4521) at a final concentration of 50 nM with a corresponding vehicle contribution of 0.6 % ( v / v ); ( c ) MPA – Base Medium supplemented with MPA (Thermo Scientific Chemicals, 461120010) dissolved in methanol at a final concentration of 1 µM with a corresponding vehicle contribution of 0.3 % ( v / v ); ( d ) Physiological mimic – Base Medium supplemented with both E2 and MPA as above, with a corresponding cumulative vehicle contribution of 0.9 % ( v / v ); ( e ) Pathological mimic – Base Medium supplemented with E2 and MPA as above, in addition to THC (Cayman Chemical, ISO60157) dissolved in methanol at a final concentration of 6 µM with a corresponding vehicle contribution of 0.2 % ( v / v ); and CBD (Cayman Chemical, ISO60156) dissolved in methanol at a final concentration of 6 µM with a corresponding vehicle contribution of 0.2 % ( v / v ); and ( f ) vehicle control – Base Medium supplemented with 1.3 % ( v / v ) methanol – identical to the largest solvent contribution (Group e ).

    Techniques: In Vivo, Expressing, Control, Software, Generated

    Contents of the main cannabinoids in Cannabis FM2 in the starting material and after decarboxylation at different temperatures, namely 115 and 125 °C. Results are expressed as mean (%, w/w) ± standard deviation (CV%).

    Journal: Pharmaceutics

    Article Title: Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose

    doi: 10.3390/pharmaceutics14122718

    Figure Lengend Snippet: Contents of the main cannabinoids in Cannabis FM2 in the starting material and after decarboxylation at different temperatures, namely 115 and 125 °C. Results are expressed as mean (%, w/w) ± standard deviation (CV%).

    Article Snippet: Cannibinoid analysis: Methanol, acetonitrile, phosphoric acid, (-)-D9-THC methanol solution at 1 mg/mL, CBD methanol solution at 1 mg/mL, standard solutions at 1 mg/mL in acetonitrile of THCA, CBDA, CBN (all analytical grade > 99%) were purchased from Sigma-Aldrich (St. Louis, MI, USA).

    Techniques: Standard Deviation

    Cannabinoids content in samples prepared using the maceration method (n = 3), expressed as % w/w (CV%): M-FM2, prepared without decarboxylation; M-FM2_115, prepared with decarboxylated FM2 at 115 °C; M-FM2_125, prepared with decarboxylated FM2 at 125 °C.

    Journal: Pharmaceutics

    Article Title: Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose

    doi: 10.3390/pharmaceutics14122718

    Figure Lengend Snippet: Cannabinoids content in samples prepared using the maceration method (n = 3), expressed as % w/w (CV%): M-FM2, prepared without decarboxylation; M-FM2_115, prepared with decarboxylated FM2 at 115 °C; M-FM2_125, prepared with decarboxylated FM2 at 125 °C.

    Article Snippet: Cannibinoid analysis: Methanol, acetonitrile, phosphoric acid, (-)-D9-THC methanol solution at 1 mg/mL, CBD methanol solution at 1 mg/mL, standard solutions at 1 mg/mL in acetonitrile of THCA, CBDA, CBN (all analytical grade > 99%) were purchased from Sigma-Aldrich (St. Louis, MI, USA).

    Techniques:

    Cannabinoid content in oily samples prepared by ultrasonic assisted extraction using no heat treated FM2 (t = 20 min) or FM2 decarboxylated at 115 °C. Aliquots of 20 mL sample were sonicated (amplitude 60%) for different time-period (n = 3, expressed as % w/w (CV%).

    Journal: Pharmaceutics

    Article Title: Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose

    doi: 10.3390/pharmaceutics14122718

    Figure Lengend Snippet: Cannabinoid content in oily samples prepared by ultrasonic assisted extraction using no heat treated FM2 (t = 20 min) or FM2 decarboxylated at 115 °C. Aliquots of 20 mL sample were sonicated (amplitude 60%) for different time-period (n = 3, expressed as % w/w (CV%).

    Article Snippet: Cannibinoid analysis: Methanol, acetonitrile, phosphoric acid, (-)-D9-THC methanol solution at 1 mg/mL, CBD methanol solution at 1 mg/mL, standard solutions at 1 mg/mL in acetonitrile of THCA, CBDA, CBN (all analytical grade > 99%) were purchased from Sigma-Aldrich (St. Louis, MI, USA).

    Techniques: Sonication

    Cannabinoids content expressed as % w/w (CV%) in samples prepared with decarboxylated FM2 by ultrasonic extraction for 10 min, using 2 mm (amplitude 60%) or 7 mm (amplitude 30%) sonotrode (50 mL sample; n = 3).

    Journal: Pharmaceutics

    Article Title: Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose

    doi: 10.3390/pharmaceutics14122718

    Figure Lengend Snippet: Cannabinoids content expressed as % w/w (CV%) in samples prepared with decarboxylated FM2 by ultrasonic extraction for 10 min, using 2 mm (amplitude 60%) or 7 mm (amplitude 30%) sonotrode (50 mL sample; n = 3).

    Article Snippet: Cannibinoid analysis: Methanol, acetonitrile, phosphoric acid, (-)-D9-THC methanol solution at 1 mg/mL, CBD methanol solution at 1 mg/mL, standard solutions at 1 mg/mL in acetonitrile of THCA, CBDA, CBN (all analytical grade > 99%) were purchased from Sigma-Aldrich (St. Louis, MI, USA).

    Techniques: